[1] 孔令环, 韩梅, 马寅芙, 等. 急性髓系白血病微小残留病检测的临床意义[J]. 中国实验诊断学, 2011, 15(4): 636.
[2] 沈悌, 赵永强. 血液病诊断及疗效标准[M]. 4版. 北京: 科学出版社, 2018: 87.
[3] 林冬, 魏辉, 王迎, 等. FLT3-ITD突变阳性急性髓系白血病的临床特征和预后因素[J]. 中华血液学杂志, 2016, 37(12): 1017.
[4] HUANG XD, VISHVA M. Crosstalk between autophagy and proteasome protein degradation systems possible implications for cancer therapy[J]. Folia Histochem Cytobiol, 2013, 51(4): 249.
[5] LIU WJ, YE L, HUANG WF, et al. p62 links the autophagy pathway and the ubiquitinproteasome system upon ubiquitinated protein degradation[J]. Cell Mol Biol Lett, 2016, 21: 29. doi: 10.1186/s11658-016-0031-z
[6] EBNER PA, VERSTEEG G, IKEDA F. Ubiquitin enzymes in the regulation of immune responses[J]. Crit Rev Biochem Mol Biol, 2017, 52(4): 425. doi: 10.1080/10409238.2017.1325829
[7] TIAN X, DAI SD, SUN J, et al. F-box protein FBXO22 mediates polyubiquitination and degradation of KLF4 to promote hepatocellular carcinoma progression[J]. Oncotarget, 2015, 6(26): 22767. doi: 10.18632/oncotarget.4082
[8] ZHANG L, CHEN J, NING D, et al. FBXO22 promotes the development of hepatocellular carcinoma by regulating the ubiquitination and degradation of p21[J]. J Exp Clin Cancer Res, 2019, 38(1): 101. doi: 10.1186/s13046-019-1058-6
[9] ZHU XN, HE P, ZHANG L, et al. FBXO22 mediates polyubiquitination and inactivation of LKB1 to promote lung cancer cell growth[J]. Cell Death Dis, 2019, 10(7): 486. doi: 10.1038/s41419-019-1732-9
[10] HOU XK, MAO JS. Long noncoding RNA SNHG14 promotes osteosarcoma progression via miR-433-3p/FBXO22 axis[J]. Biochem Biophys Res Commun, 2020, 523(3): 766. doi: 10.1016/j.bbrc.2020.01.016
[11] 宋虎, 张亚飞, 徐为, 等. FBXO22对结肠癌细胞侵袭迁移的影响及相关机制[J]. 南京医科大学学报(自然科学版), 2017, 37(12): 1553. doi: 10.7655/NYDXBNS20171203
[12] 胡林义, 张萌, 白津, 等. FBXO22在卵巢癌中的表达和临床意义[J]. 徐州医科大学报, 2018, 38(3): 191.
[13] HE YR, WANG YF, LIU L, et al. Circular RNA circ_0006282 contributes to the progression of gastric cancer by sponging miR-155 to upregulate the expression of FBXO22[J]. Onco Targets Ther, 2020, 13: 1001. doi: 10.2147/OTT.S228216
[14] GUO F, LIU JJ, HAN X, et al. FBXO22 suppresses metastasis in human renal cell carcinoma via inhibiting MMP-9-mediated migration and invasion and VEGF-mediated angiogenesis[J]. Int J Biol Sci, 2019, 15(3): 647. doi: 10.7150/ijbs.31293
[15] 方虹舒, 张薇. FBXO22对乳腺癌细胞侵袭迁移能力的影响[J]. 国际检验医学杂志, 2019, 40(10): 1157. doi: 10.3969/j.issn.1673-4130.2019.10.002
[16] SUN R, XIE HY, QIAN JX, et al. FBXO22 possesses both protumorigenic and antimetastatic roles in breast cancer progression[J]. Cancer Res, 2018, 78(18): 5274. doi: 10.1158/0008-5472.CAN-17-3647
[17] JOHMURA Y, SUN J, KITAGAWA K, et al. SCF(Fbxo22)-KDM4A targets methylated p53 for degradation and regulates senescence[J]. Nat Commun, 2016, 7: 10574. doi: 10.1038/ncomms10574
[18] ZHENG XQ, YU SW, XUE Y, et al. FBXO22, ubiquitination degradation of PHLPP1, ameliorates rotenone induced neurotoxicity by activating AKT pathway[J]. Toxicol Lett, 2021, 350: 1. doi: 10.1016/j.toxlet.2021.06.017
[19] SUZUKI N, JOHMURA Y, WANG T, et al. TP53/p53-FBXO22-TFEB controls basal autophagy to govern hormesis[J]. Autophagy, 2021, 17(11): 1.
[20] WU B, LIU ZY, CUI J, et al. F-Box protein FBXO22 mediates polyubiquitination and degradation of CD147 to reverse cisplatin resistance of tumor cells[J]. Int J Mol Sci, 2017, 18(1): 212.
[21] DIKOPOLTSEV E, FOLTYN V, ZEHL M, et al. FBXO22 protein is required for optimal synthesis of the N-methyl-D-aspartate (NMDA) receptor coagonist D-serine[J]. J Biol Chem, 2014, 289(49): 33904.
[22] 姜艳红, 焦扬, 陈光意, 等. 不同血小板数量分层在儿童初治原发急性髓系白血病中的临床意义[J]. 中华实用儿科临床杂志, 2021, 36(3): 204.
[23] 庞艳彬, 范丽霞, 赵松颖, 等. 首次诱导治疗后的血小板计数与急性髓系白血病无复发生存期的关系[J]. 广东医学, 2018, 39(5): 717.
[24] 向丹, 沈建良, 黄有章, 等. 巨核细胞、血小板动态变化对急性白血病疗效和预后的意义150例分析与文献复习[J]. 海军总医院学报, 2004, 12(7): 109.